EE357 Implementing the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach – A Case Example in HCV Therapies
Abstract
Authors
M. Graf J. Chou O. Díaz Espinosa I. Brewer Z. Heim J.R. Baumgardner
M. Graf J. Chou O. Díaz Espinosa I. Brewer Z. Heim J.R. Baumgardner
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now